iPAX‑2 Trial of TLX101 TX in First‑Line Glioblastoma Finishes Enrollment and Locks In Dosing Schedule
iPAX‑2 Trial of TLX101 in First‑Line Glioblastoma Hits Full Enrollment and Dosing Confirmation
A Glimmer of Hope: UNC Researchers Uncover Potent Combination Therapy for Aggressive Brain Cancer
A New Chapter in Cancer Diagnostics: Humana Covers CNSide Assay
The Brain's Silent Battle: Decades of Discovery in the Fight Against Tumors
Beyond the Brain's Confines: Unmasking Glioblastoma's Bone-Eating Secret
Narayana Health City Achieves Monumental Milestone: Over 100,000 Neurology Procedures Transforming Lives
A New Dawn in Pediatric Brain Cancer Research: Collaborative Trials Ignite Hope